Renal Cancer - GEN - Genetic Engineering and Biotechnology News

Eye Disorders

StockWatch: Failed Trial Sinks NGM Bio; Will Merck Opt Into Eye Disorder Drug?

Scientists Working in The Laboratory, Using Touch Screen

Renal Cancer

Immunotherapy Improved with Use of Ultrasound-Guided Microbubbles

Immuno-oncology

StockWatch: Checkmate Shares Quadruple on Regeneron Buyout

Coronavirus

GEN Edge StockWatch: Investors Warm to Moderna’s COVID-19 Sales, Vaccine Updates

Micrograph of Renal Cell Carcinoma (RCC)

Renal Cancer

Researchers Discover a Way to Predict Kidney Cancer’s Response to Immunotherapy

Micrograph of Renal Cell Carcinoma (RCC)

Renal Cancer

Allarity Therapeutics and Lonza Collaborate to Manufacture Dovitinib

Renal Cancer

Cellares’ Automation Route for Cancer Cell Therapy

Human kidneys, illustration

Renal Cancer

Scientists Identify Origins and Cellular Signals of Seven Childhood and Adult...

Human kidneys and adrenal glands, illustration

Renal Cancer

Unknown Immune Cell Helps Predict Kidney Cancer Recurrence

Human kidneys and adrenal glands, illustration

Renal Cancer

Promising Triple Therapy Approach Identified for Renal Cell Carcinoma

Human kidneys, illustration

Renal Cancer

Researchers Discover Key Structures in Kidney Formation

Renal Cancer

Merck & Co. to Acquire Peloton for Up to $2.2B, Adding...

Renal Cancer

Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership

Renal Cancer

Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy into the...

Renal Cancer

Acceleron Halts Development of Cancer Candidate Dalantercept

12 3 4 Page 1 of 4